Pentasa uses are mainly focused on the treatment of ulcerative colitis. By inhibiting the production of chemicals that lead to the inflammation often caused by ulcerative colitis, the medication can improve the symptoms of the condition. Pentasa has not been approved for use in children. "Off-label" Pentasa uses include the treatment of Crohn's disease, another condition that affects the gastrointestinal tract.
Pentasa® (mesalamine) is a prescription medicine that has been licensed to treat ulcerative colitis. It is part of a group of medications known as aminosalicylates.
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that leads to inflammation and sores in the lining of the large intestine and rectum. It commonly causes abdominal pain, diarrhea, and other symptoms, like rectal bleeding or extreme urgency to have a bowel movement. At this time, the causes of ulcerative colitis are not fully understood. Although ulcerative colitis complications can be quite severe, there is only one ulcerative colitis cure -- surgery. Other than surgery (see Ulcerative Colitis Surgery), ulcerative colitis treatment options include the following: